Beryl Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Beryl Capital Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-514,114	Closed	-$11M	–	9
2026 Q1	$11M	Buy	+514,114	New	+$7.24M	10.05%	4

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Beryl Capital Management's DAWN Position: Q2 2026 in Review

Beryl Capital Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 514,114 shares — an estimated $11M sold.

Beryl Capital Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $11M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Beryl Capital Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Beryl Capital Management sold 514,114 Day One Biopharmaceuticals shares in Q2 2026, an estimated $11M.
Beryl Capital Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Beryl Capital Management's Day One Biopharmaceuticals position peaked at $11M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Beryl Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.